Skip to content

Mitoxantrone

Novantrone (mitoxantrone) is a small molecule pharmaceutical. Mitoxantrone was first approved as Novantrone on 1987-12-23. It is used to treat breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, and pain amongst others in the USA. It is known to target DNA topoisomerase 2-alpha and DNA topoisomerase 2-beta.
Trade Name Novantrone
Common Name Mitoxantrone
Indication breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, pain, prostatic neoplasms, sarcoma
Drug Class Antineoplastics, anthraquinone derivatives
Mitoxantrone
Get full access now